What this record means
The record shows a live, pending application for the mark DR.BABOON owned by Niusaisi Guangzhou Biotechnology Co., Ltd., a limited company organized in China, and it is currently published for opposition as of October 6, 2026. The only listed goods fall in International Class 5 and cover health‑food supplements, dietetic foods and beverages adapted for medical use, dietary supplements for humans and animals, dietetic animal foodstuffs for medical purposes, and nutritional supplements in forms such as capsules, tablets, powders, syrups, gummies and gels. Because the claim is limited to these pharmaceutical‑related products, a similar name used for, say, clothing or software would be farther from the scope shown, while another health‑supplement brand using “DR.BABOON” would raise the closest concern. The prosecution history shows the application was approved for publication on the Principal Register and then entered an examiner’s amendment on September 10, 2026, but no supplemental‑register filing appears. The latest meaningful event is the official Gazette publication on October 6, 2026, and the supplied history contains no opposition filings or other enforcement actions. I'd treat this as a meaningful concern if you plan a comparable name in the same supplement market.
Informational only - not legal advice.Goods & services
Health food supplements; Dietetic foods and beverages adapted for medical use; Dietary supplements for humans and animals; Dietetic animal foodstuffs for medical purposes; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies, gels
First use: Mar 25, 2026
Use in commerce: Mar 25, 2026